Edwards Lifesciences recently announced a final agreement with Becton, Dickinson and Company to sell its entire intensive care product line to them for $4.2 billion in cash. Based on this agreement, ...

With the continuous amplification of spillover effects, CIIE has become an important platform for multinational pharmaceutical companies to expand into the Chinese market. On November 6th, 2024, Merc ...